Representative before the EPO

Technology company logo thumb
no operation time available
3 offices
Technology Company

Lindsey Ruth Kent has worked on the following 27 EPO patent applications which have been published in the last five years:

EP12719889

c-KIT ANTIBODIES AND USES THEREOF

IPC classification:
A61K 39/395, A61K 45/06, C07K 16/28
Agent:
Lindsey Ruth Kent, Eli Lilly and Company Limited
Status:
PATENT GRANTED
EP12761863

ANTIBODIES TO PCSK9 AND USES THEREOF

IPC classification:
C07K 16/40
Applicant:
Eli Lilly and Company Limited
Agent:
Lindsey Ruth Kent, Eli Lilly and Company Limited
Status:
EXAMINATION IN PROGRESS
EP12833842

ANTI-C-MET ANTIBODIES

IPC classification:
A61K 39/395, C07K 16/00, C12P 21/08
Applicant:
Eli Lilly and Company Limited
Agent:
Lindsey Ruth Kent, Eli Lilly and Company Limited
Status:
APPLICATION WITHDRAWN
EP14181801

Anti-myostatin antibodies

IPC classification:
A61K 39/395, A61P 3/00, A61P 21/00, C07K 16/22
Applicant:
Eli Lilly and Company Limited
Agent:
Lindsey Ruth Kent, Eli Lilly and Company Limited
Status:
EXAMINATION IN PROGRESS
EP13710214

IL-17 ANTIBODY FORMULATION

IPC classification:
A61K 39/395, C07K 16/24
Applicant:
Eli Lilly and Company Limited
Agent:
Lindsey Ruth Kent, Eli Lilly and Company Limited
Status:
PATENT GRANTED
EP14190162

Pegylated amyloid beta fab

IPC classification:
A61K 39/395, A61K 47/48, A61P 25/28, C07K 16/18, C12N 15/13
Applicant:
Eli Lilly and Company Limited
Agent:
Lindsey Ruth Kent, Eli Lilly and Company Limited
Status:
PATENT GRANTED
EP13724063

TREATMENT FOR COMORBID DIABETES WITH CHRONIC KIDNEY DISEASE

IPC classification:
A61K 47/48, A61P 3/10
Applicant:
Eli Lilly and Company Limited
Agent:
Lindsey Ruth Kent, Eli Lilly and Company Limited
Status:
EXAMINATION REQUESTED
EP13787192

ANTI-C-MET ANTIBODIES

IPC classification:
C07K 16/28
Applicant:
Eli Lilly and Company Limited
Agent:
Lindsey Ruth Kent, Eli Lilly and Company Limited
Status:
The patent has been granted
EP15159780

DKK-1 ANTIBODIES

IPC classification:
A61K 39/00, C07K 16/18
Applicant:
Eli Lilly and Company Limited
Agent:
Lindsey Ruth Kent, Eli Lilly and Company Limited
Status:
EXAMINATION IN PROGRESS
EP13178615

Anti-sclerostin antibodies

IPC classification:
A61K 39/395, A61P 19/08, A61P 19/10, C07K 16/22
Agent:
Lindsey Ruth Kent, Eli Lilly and Company Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15175051

C-MET ANTIBODIES

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28
Applicant:
Eli Lilly and Company Limited
Agent:
Lindsey Ruth Kent, Eli Lilly and Company Limited
Status:
EXAMINATION REQUESTED
EP14711895

ANTI-TNF-ANTI-IL-17 BISPECIFIC ANTIBODIES

IPC classification:
A61K 39/395, A61P 17/06, A61P 19/02, C07K 16/24
Applicant:
Eli Lilly and Company Limited
Agent:
Lindsey Ruth Kent, Eli Lilly and Company Limited
Status:
EXAMINATION IN PROGRESS
EP14711899

PAN-ELR+ CXC CHEMOKINE ANTIBODIES

IPC classification:
C07K 16/18, C07K 16/24
Applicant:
Eli Lilly and Company Limited
Agent:
Lindsey Ruth Kent, Eli Lilly and Company Limited
Status:
EXAMINATION IN PROGRESS
EP11745672

ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF

IPC classification:
A61K 39/395, A61P 25/28, C07K 16/18, G01N 33/577
Applicant:
Eli Lilly and Company Limited
Agent:
Lindsey Ruth Kent, Eli Lilly and Company Limited
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15196358

ANTI-N3PGLU AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF

IPC classification:
A61K 39/395, A61P 25/28, C07K 16/18, G01N 33/577
Applicant:
Eli Lilly and Company Limited
Agent:
Lindsey Ruth Kent, Eli Lilly and Company Limited
Status:
EXAMINATION IN PROGRESS
EP11711424

NOVEL PEPTIDES AND METHODS FOR THEIR PREPARATION AND USE

IPC classification:
A61K 38/16, A61K 38/26, A61K 38/30, C07K 14/47, C07K 14/605, C07K 14/62
Agent:
Lindsey Ruth Kent, Eli Lilly and Company Limited
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14821418

NOVEL COMPOUND FOR TREATMENT OF SEVERE HYPOGLYCEMIA

IPC classification:
C07K 14/605
Applicant:
Eli Lilly and Company Limited
Agent:
Lindsey Ruth Kent, Eli Lilly and Company Limited
Status:
APPLICATION WITHDRAWN
EP14821985

NOVEL COMPOUND FOR TREATMENT OF SEVERE HYPOGLYCEMIA

IPC classification:
C07K 14/605
Applicant:
Eli Lilly and Company Limited
Agent:
Lindsey Ruth Kent, Eli Lilly and Company Limited
Status:
EXAMINATION REQUESTED
EP14821986

NOVEL COMPOUND FOR TREATMENT OF SEVERE HYPOGLYCEMIA

IPC classification:
A61K 38/00, C07K 14/605
Applicant:
Eli Lilly and Company Limited
Agent:
Lindsey Ruth Kent, Eli Lilly and Company Limited
Status:
EXAMINATION REQUESTED
EP14830758

MULTIFUNCTIONAL ANTIBODIES BINDING TO EGFR AND MET

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28, C07K 16/30, C07K 16/46
Applicant:
Eli Lilly and Company Limited
Agent:
Lindsey Ruth Kent, Eli Lilly and Company Limited
Status:
EXAMINATION REQUESTED
EP15764397

IL-21 ANTIBODIES

IPC classification:
C07K 16/24
Applicant:
Eli Lilly and Company Limited
Agent:
Lindsey Ruth Kent, Eli Lilly and Company Limited
Status:
EXAMINATION REQUESTED
EP15723388

RAPID-ACTING INSULIN COMPOSITIONS

IPC classification:
A61K 31/5585, A61K 38/28, A61P 3/10
Applicant:
Eli Lilly and Company Limited
Agent:
Lindsey Ruth Kent, Eli Lilly and Company Limited
Status:
EXAMINATION REQUESTED
EP16195503

IL-17 ANTIBODY FORMULATION

IPC classification:
A61K 39/395, C07K 16/24
Applicant:
Eli Lilly and Company Limited
Agent:
Lindsey Ruth Kent, Eli Lilly and Company Limited
Status:
APPLICATION PUBLISHED
EP15734541

THERAPY FOR GIST

IPC classification:
A61K 39/00, A61P 35/00, C07K 16/28
Agent:
Lindsey Ruth Kent, Eli Lilly and Company Limited
Status:
EXAMINATION REQUESTED
EP15734537

COMBINATION THERAPY

IPC classification:
A61K 31/704, A61K 39/395, A61P 35/00, C07K 16/28, C07K 16/30
Agent:
Lindsey Ruth Kent, Eli Lilly and Company Limited
Status:
EXAMINATION REQUESTED
EP15817678

RAPID-ACTING INSULIN COMPOSITIONS

IPC classification:
A61K 38/28, A61K 47/12, A61P 3/10
Applicant:
Eli Lilly and Company Limited
Agent:
Lindsey Ruth Kent, Eli Lilly and Company Limited
Status:
Request for examination was made
EP16703620

GIP AND GLP-1 CO-AGONIST COMPOUNDS

IPC classification:
A61K 38/26, C07K 14/575, C07K 14/605
Applicant:
Eli Lilly and Company Limited
Agent:
Lindsey Ruth Kent, Eli Lilly and Company Limited
Status:
Request for examination was made

Please Sign in to use this feature